Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Menopause. 2012 Jun;19(6):664–671. doi: 10.1097/gme.0b013e31823dbbe3

Table 1.

Total Number of Events and Percentage Agreement for Phases 1 and 2 Laboratory Studies by Subgroup and Measure

Phase 1
Laboratory Evaluation
Phase 2
Laboratory Evaluation
Midlife
VMS
(n = 2)
Midlife no
VMS
(n =2)
Young
no VMS
(n = 2)
Midlife
VMS
(n = 5)
Midlife
no VMS
(n = 5)
Young
no VMS
(n = 5)
Bahr Monitor™
 Total # event marks* 5 0 0 13 0 1
 Total # monitor VMS* 5 0 1 18 0 1
Bahr Monitor™ to Event Mark
 Event mark + monitor 5 0 0 13 0 1
 Event mark only 0 0 0 0 0 0
 Monitor only 0 0 1 5 0 0
 % event marks with monitor-recorded VMS 100% NA NA 100% NA 100%
 % monitor-recorded VMS with event mark 100% NA 0% 72% NA 100%
Freedman Monitor NA NA NA
 Total # event marks* 4 0 0
 Total # monitor VMS* 12 7 6
Freedman Monitor™ to Event Mark NA NA NA
 Event mark + monitor 4 0 0
 Event mark only 0 0 0
 Monitor only 8 7 6
 % event marks with monitor-recorded VMS 100% NA NA
 % monitor-recorded VMS with event mark 67% 0% 0%
Biolog™ Monitor NA NA NA
 Total event marks* 14 0 0
 Total monitor VMS* 15 4 0
Biolog™ Monitor to Event Mark NA NA NA
 Event mark + monitor 12 0 0
 Event mark only 2 0 0
 Monitor only 3 4 3
 % event marks with monitor-recorded VMS 86% NA NA
 % monitor-recorded VMS with event mark VMS 80% 0% NA
Bahr Monitor™ to Freedman NA NA NA
 Bahr™ + Freedman 5 0 1
 Bahr™ only 0 0 0
 Freedman only 7 7 5
 % agreement 42% 0% 17%
Bahr Monitor™ to Biolog™ NA NA NA
 Bahr™ + Biolog™ 14 0 0
 Bahr™ only 4 0 1
 Biolog™ only 1 4 0
 % agreement 74% 0% 0%

VMS = vasomotor symptom (hot flash, night sweat).

NA = not applicable, monitor not tested.

*

Total event marks and total monitor VMS = number of each after collating to remove duplicate events. Events marks in non-VMS groups can be interpreted as false button presses.